Form D Explorer

Form D — Halia Therapeutics, Inc.

0001829255-26-000001 · filed Aug 31, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$20,000,000
Reported amount sold
$3,486,474
Minimum investment
$0
Investors
9
Sales commission
$0
Finders' fees
$0

Issuer

Name
Halia Therapeutics, Inc.
CIK
1829255
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
3900 N. Traverse Mountain Blvd.
Lehi, UT 84043
Phone
801-842-1652

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗